CLINICAL_TRIALS
trial_result
· 2018-05-07
Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne [Phase 3]
Summary
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating Sarecycline for acne vulgaris has completed, and the results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Almirall, S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2018-05-07